Drug Shortage Report for METHOTREXATE INJECTION USP
Report ID | 64245 |
Drug Identification Number | 02398427 |
Brand name | METHOTREXATE INJECTION USP |
Common or Proper name | METHOTREXATE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | METHOTREXATE |
Strength(s) | 25MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRA-ARTERIAL INTRAMUSCULAR INTRAVENOUS |
Packaging size | 2MLx1 VIAL |
ATC code | L01BA |
ATC description | ANTIMETABOLITES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2018-09-28 |
Estimated end date | Unknown |
Actual end date | 2023-07-07 |
Shortage status | Resolved |
Updated date | 2023-11-17 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-10-15 | English | Compare |
v2 | 2018-10-15 | French | Compare |
v3 | 2018-12-13 | English | Compare |
v4 | 2018-12-13 | French | Compare |
v5 | 2019-01-16 | English | Compare |
v6 | 2019-01-16 | French | Compare |
v7 | 2019-04-15 | English | Compare |
v8 | 2019-04-15 | French | Compare |
v9 | 2019-04-18 | English | Compare |
v10 | 2019-04-18 | French | Compare |
v11 | 2019-11-06 | English | Compare |
v12 | 2019-11-06 | French | Compare |
v13 | 2019-11-19 | English | Compare |
v14 | 2019-11-19 | French | Compare |
v15 | 2019-12-05 | English | Compare |
v16 | 2019-12-05 | French | Compare |
v17 | 2019-12-06 | English | Compare |
v18 | 2019-12-06 | French | Compare |
v19 | 2020-06-08 | English | Compare |
v20 | 2020-06-08 | French | Compare |